AI
SNDX icon

Atom Investors’s Syndax Pharmaceuticals SNDX Stock Holding History

Atom Investors’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.55M Buy
162,524
+6,559
+4% +$136K 0.32% 48
2026
Q1 		$3.64M Buy
155,965
+14,299
+10% +$311K 0.26% 119
2025
Q4 		$2.98M Buy
+141,666
New +$2.47M 0.24% 144
2025
Q3 		– Sell
-13,104
Closed -$123K – 799
2025
Q2 		$123K Sell
13,104
-44,170
-77% -$486K 0.01% 538
2025
Q1 		$704K Sell
57,274
-5,521
-9% -$77.9K 0.09% 258
2024
Q4 		$830K Buy
+62,795
New +$1.07M 0.1% 266

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Atom Investors's SNDX Position: Q2 2026 in Review

Atom Investors increased its Syndax Pharmaceuticals (SNDX) stake by 4.2% in Q2 2026, buying an estimated $136K and bringing the position to 162,524 shares worth $3.55M. The position accounts for 0.32% of the portfolio, ranked #48.

Atom Investors first reported a position in SNDX in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.64M in Q1 2026. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Atom Investors held 162,524 shares of Syndax Pharmaceuticals worth $3.55M as of Q2 2026.
  • Atom Investors bought 6,559 Syndax Pharmaceuticals shares in Q2 2026, an estimated $136K.
  • Syndax Pharmaceuticals made up 0.32% of Atom Investors's portfolio in Q2 2026, its #48 holding.
  • Atom Investors first reported a position in Syndax Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Atom Investors's Syndax Pharmaceuticals position peaked at $3.64M in Q1 2026.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.